SPE Capital Partners has announced the acquisition of Saham Pharma, an antibiotics manufacturer and hospital provider in Morocco, alongside Proparco as a minority investor.
Share this post
SPE Capital Partners and Proparco acquire…
Share this post
SPE Capital Partners has announced the acquisition of Saham Pharma, an antibiotics manufacturer and hospital provider in Morocco, alongside Proparco as a minority investor.